可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Mehta JL, Saldeen TG,Rand K et al. Interaction role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease[J]. J Am Coll Cardial,1998,31(4):1217-1218.
[2] Ridker PM. Clinical application of Creactive protein for cardiovascular disease detection and prevention [J]. Circulation,2003,107(3):369-371.
[3] Ridker PM, Morrow D. Highsensitivity Creactive protein and cardiovascular risk[J]. Am J Cardiol,2003,92(Suppl):17-22.
[4] Pascri V.willerson JT,Yeh ETH. Direct proinflammatory effect of creactive protein on human endothelial cells[J], Circulation,2000,102(18):2165-2168.
[5] 李后开,戴敏. 内皮细胞炎症反应在动脉粥样硬化研究中的作用[J]. 中国动脉梗化杂志,2004,12(5):607-610.
[6] Tataru MC, Heinrich J, Junker R, et al. Creactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris[J]. Eur Heart J, 2000,21(3):1000-1002.
[7] 陈协辉,陈晓君. 冠心病患者介入治疗前后血清C反应蛋白变化与心血管事件和再狭窄的关系[J].中国综合临床,2005,21(9):774-776.
[8] 陈协辉,陈晓君.介入治疗对急性冠脉综合症血浆CRP影响的观察[J].中国医师杂志,2004,6(12):1692-1693.
[9] Eren E, Yilmaz N, Pence S, et al. Diagnostic value of Creactive protein in patients with angiographically documented coronary heart disease[J]. Acta Medica, 2002,45(4):155-160.
[10]Nomoto K, Oguchi S, Watanabe I, et al, Involvement of inflammation in acute coronary syndromes assessed by levels of highsensitivity Creactive protein, matrix metalloproteinase9 and soluble vascularcell adhesion molecule1[J]. J Cardiol,2003,42(5):201-206.
[11]崔红玉.C反应蛋白在不同类型冠心病间的差异[J]. 心脏杂志,2005,17(6):620.
[12]Yamashita H,Shimada K,Seki E, et al. Concentrations of inter leukins ,interferon ,and Creactive protein in stable and unstable angina pectoris [J]. Am J Cardiol, 2003,91(2):133-136.